Targeted PEG-based bioconjugates enhance the cellular uptake and transport of a HIV-1 TAT nonapeptide
- 27 November 2001
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 77 (3), 199-212
- https://doi.org/10.1016/s0168-3659(01)00474-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Novel Approaches for Oral Delivery of MacromoleculesJournal of Pharmaceutical Sciences, 1998
- Direct Evidence for Peptide Transporter (PepT1)-Mediated Uptake of a Nonpeptide Prodrug, ValacyclovirBiochemical and Biophysical Research Communications, 1998
- Modulation of Intestinal Permeability: An Innovative Method of Oral Drug Delivery for the Treatment of Inherited and Acquired Human DiseasesMolecular Genetics and Metabolism, 1998
- The challenge of proteolytic enzymes in intestinal peptide deliveryJournal of Controlled Release, 1997
- Absorption of Peptide and Peptidomimetic DrugsAnnual Review of Pharmacology and Toxicology, 1994
- Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugsJournal of Controlled Release, 1994
- Mechanisms of absorption enhancement and tight junction regulationJournal of Controlled Release, 1994
- Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cellsThe Journal of cell biology, 1992
- Structural Specificity of Mucosal-Cell Transport and Metabolism of Peptide Drugs: Implication for Oral Peptide Drug DeliveryPharmaceutical Research, 1992
- Penetration and enzymatic barriers to peptide and protein absorptionAdvanced Drug Delivery Reviews, 1989